Combining “fit, filtration and efficiency” is the key to enhancing protection and encouraging compliance.
In order to meet the worldwide need for faster and affordable testing processes, companies must shift goals and apply resources to ending this pandemic.
The authorization is a step toward broad screening that will help reopen schools and workplaces in America, says FDA Commissioner Stephen Hahn, M.D.
Illumina’s COVIDSeq Test enables qualitative detection of SARS-CoV-2 RNA from respiratory specimens.
COVID-19 requires us to rethink our current device disinfection procedure.
Diagnostic companies are hustling to increase availability of testing.